Company intelligence / Profile preview

Shandong Shengdi Pharmaceutical

Jinan, Shandong, Chinadnb.com ↗

Ownership: Private
Development stage: Other

Overview

Shandong Shengdi Pharmaceutical is a Chinese pharmaceutical manufacturer engaged in the research, development, and production of innovative drug products. The company has several small molecule candidates in its pipeline, including HRS-5346 currently in Phase 2 clinical trials. Its focus includes anti-HIV therapies and other areas of unmet medical need. No approved products or major late-stage assets are publicly reported.

Modalities: Small molecule
Industry: Biotech

Partnerships

Shanghai Tuojie Biopharmaceutical Technology Co., Ltd.Beijing Shengdi Pharmaceutical Co., Ltd.

Beyond the preview

Go deeper on Shandong Shengdi Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shandong Shengdi Pharmaceutical.

Explore the full profile